NPPA Turns to Patent Office for Clarity on Drug Price Exemptions, Defers Intas, Biological E's Applications Farhat Nasim20 Dec 2024 6:11 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has sought expertise from the Indian Patent Office to assist in making decisions...
Bajaj Healthcare moves patent office after Eli Lilly refuses to ink Baricitinib agreement Medical Dialogues Team28 Jun 2021 5:45 PM ISTNew Delhi: With Eli Lilly denying to ink voluntary licensing agreement for Baricitinib, Bajaj Healthcare Ltd (BHL) has approached the Indian patent...
Venus Remedies wins decade long battle against French firm to cancel patent for Paracetamol Medical Dialogues Team18 Jun 2021 4:54 PM ISTNew Delhi: In a historical breakthrough for the pharmaceutical industry in India, Himachal Pradesh-based Venus Remedies has won a 10-year long legal...
India rejects patent claim to Pfizer Pooja Bhatia Bhatia8 Sept 2015 10:48 AM ISTIndia has reportedly again denied Pfizer a patent of rheumatoid arthritis drug tofacitinibPfizer has reportedly sought a patent right over rheumatoid...
